Cardiovascular therapeutic targets of sodium-glucose co-transporter 2 (SGLT2) inhibitors beyond heart failure

Anti-Inflammatory Effects of SGLT2 Inhibitors: Focus on Macrophages

Empagliflozin improves primary haemodynamic parameters and attenuates the development of atherosclerosis in high fat diet fed APOE knockout mice

Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice